Among the tumor genes (SI Appendix, Fig. S5A), we note some that have been implicated in mTOR activation (MAP2K6 and IL17RC) or inhibition (GJB3) and were upregulated or downregulated, respectively, in everolimus-adapted (LT) tumors. Here, MAP2K6 is linked to neoplasm.